Enhanced Genomics raises £14m Series A from investors to advance therapeutics pipeline with its 3D multi-omics platform

Enhanced Genomics uses a three-dimensional multi-omics platform to identify genetically validated drug targets, supporting the development of new medicines for complex common diseases.